Invesco Ltd. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,229,000
+1983.3%
114,245
+971.0%
0.00%
Q2 2022$203,000
-17.8%
10,667
+16.9%
0.00%
Q1 2022$247,000
-97.1%
9,122
-96.6%
0.00%
-100.0%
Q4 2020$8,568,000
-14.0%
267,155
+0.8%
0.00%
-33.3%
Q3 2020$9,968,000
-31.0%
264,965
-17.9%
0.00%
-40.0%
Q2 2020$14,443,000
+59.1%
322,741
+21.3%
0.01%
+25.0%
Q1 2020$9,077,000
-13.6%
266,118
-1.2%
0.00%
+33.3%
Q4 2019$10,500,000269,2370.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders